Literature DB >> 9188218

Pertussis notifications in Australia, 1991 to 1997.

R Andrews1, A Herceg, C Roberts.   

Abstract

Although pertussis is a vaccine-preventable disease, it has been epidemic in Australia since 1993 and recently claimed the lives of four children under three months of age. We reviewed national notifications of pertussis from 1991 to 1997 and found notification rates ranged from 2.0 per 100,000 population in 1991 to a peak of 30.5 per 100,000 population in 1994 despite pertussis vaccination coverage approaching 90% for the three-dose primary course. We found that notification rates were highest in infants (< 1 year of age) and school aged children (5-14 years of age). Although there was a resurgence of pertussis in 1996, age-specific notification rates decreased for children aged 1-7 years and it appears that the diphtheria-tetanus-pertussis (DTP) booster introduced as a fifth dose at 4-5 years may be having an effect. We raise the possibility that the current whole cell pertussis vaccine may be providing only short-term immunity and that our results may reflect low or inadequate vaccine coverage among both the population at large and the individual cases. We identify gaps in the national surveillance system which require attention including under-reporting and the need for information on vaccination status of notified cases; method of diagnosis; and date of birth or age in months to identify the proportion of infants in the highest risk group, that is under six months of age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188218

Source DB:  PubMed          Journal:  Commun Dis Intell        ISSN: 0725-3141


  34 in total

1.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.

Authors:  F R Mooi; Q He; H van Oirschot; J Mertsola
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland.

Authors:  I Letowska; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-27       Impact factor: 3.267

7.  Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles.

Authors:  Abdolreza Advani; Declan Donnelly; Hans Hallander
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.

Authors:  Gaëtan Muyldermans; Denis Piérard; Nathalie Hoebrekx; Reza Advani; Shirley Van Amersfoorth; Iris De Schutter; Oriane Soetens; Leo Eeckhout; Anne Malfroot; Sabine Lauwers
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.

Authors:  Atsuko Kodama; Kazunari Kamachi; Yoshinobu Horiuchi; Toshifumi Konda; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

10.  Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.

Authors:  Si Ying Ho; Shi Qian Chua; Damian G W Foo; Camille Locht; Vincent T Chow; Chit Laa Poh; Sylvie Alonso
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.